Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 225

1.

Strategies for Reducing Myocardial Infarct Size Following STEMI.

Paradies V, Chan MHH, Hausenloy DJ.

In: Watson TJ, Ong PJL, Tcheng JE, editors. Primary Angioplasty: A Practical Guide [Internet]. Singapore: Springer; 2018. Chapter 22.
2018 Jul 14.

2.

Independent Predictors of Cardiac Mortality and Hospitalization for Heart Failure in a Multi-Ethnic Asian ST-segment Elevation Myocardial Infarction Population Treated by Primary Percutaneous Coronary Intervention.

Bulluck H, Zheng H, Chan MY, Foin N, Foo DC, Lee CW, Lim ST, Sahlen A, Tan HC, Tan JW, Tong KL, Wong AS, Wong PE, Yeo KK, Foo LL, Chua TS, Koh TH, Hausenloy DJ.

Sci Rep. 2019 Jul 11;9(1):10072. doi: 10.1038/s41598-019-46486-0.

3.

Cardiac MRI Endpoints in Myocardial Infarction Experimental and Clinical Trials: JACC Scientific Expert Panel.

Ibanez B, Aletras AH, Arai AE, Arheden H, Bax J, Berry C, Bucciarelli-Ducci C, Croisille P, Dall'Armellina E, Dharmakumar R, Eitel I, Fernández-Jiménez R, Friedrich MG, García-Dorado D, Hausenloy DJ, Kim RJ, Kozerke S, Kramer CM, Salerno M, Sánchez-González J, Sanz J, Fuster V.

J Am Coll Cardiol. 2019 Jul 16;74(2):238-256. doi: 10.1016/j.jacc.2019.05.024. Review.

4.

Optimized Treatment of ST-Elevation Myocardial Infarction.

Niccoli G, Montone RA, Ibanez B, Thiele H, Crea F, Heusch G, Bulluck H, Hausenloy DJ, Berry C, Stiermaier T, Camici PG, Eitel I.

Circ Res. 2019 Jul 5;125(2):245-258. doi: 10.1161/CIRCRESAHA.119.315344. Epub 2019 Jul 3.

PMID:
31268854
5.

Interrogation of the infarcted and salvaged myocardium using multi-parametric mapping cardiovascular magnetic resonance in reperfused ST-segment elevation myocardial infarction patients.

Hausenloy DJ, Lim MX, Chan MHH, Paradies V, Francis R, Kotecha T, Knight DS, Fontana M, Kellman P, Moon JC, Bulluck H.

Sci Rep. 2019 Jun 21;9(1):9056. doi: 10.1038/s41598-019-45449-9.

6.

Magnetic Resonance Perfusion or Fractional Flow Reserve in Coronary Disease.

Nagel E, Greenwood JP, McCann GP, Bettencourt N, Shah AM, Hussain ST, Perera D, Plein S, Bucciarelli-Ducci C, Paul M, Westwood MA, Marber M, Richter WS, Puntmann VO, Schwenke C, Schulz-Menger J, Das R, Wong J, Hausenloy DJ, Steen H, Berry C; MR-INFORM Investigators.

N Engl J Med. 2019 Jun 20;380(25):2418-2428. doi: 10.1056/NEJMoa1716734.

PMID:
31216398
7.

Time-Stratified Case Crossover Study of the Association of Outdoor Ambient Air Pollution With the Risk of Acute Myocardial Infarction in the Context of Seasonal Exposure to the Southeast Asian Haze Problem.

Ho AFW, Zheng H, Earnest A, Cheong KH, Pek PP, Seok JY, Liu N, Kwan YH, Tan JWC, Wong TH, Hausenloy DJ, Foo LL, Tan BYQ, Ong MEH.

J Am Heart Assoc. 2019 Mar 19;8(6):e011272. doi: 10.1161/JAHA.118.011272.

8.

Role of Macrophages in Cardioprotection.

Yap J, Cabrera-Fuentes HA, Irei J, Hausenloy DJ, Boisvert WA.

Int J Mol Sci. 2019 May 19;20(10). pii: E2474. doi: 10.3390/ijms20102474. Review.

9.

Feasibility to Perform T2 * Mapping Postcontrast Administration in Reperfused STEMI Patients for the Detection of Intramyocardial Hemorrhage.

Bulluck H, Chowdhury N, Lim MX, Allen JC, Bryant JA, Chan MY, Chan MHH, Chin CWL, Ho HH, Lim ST, Tan RS, Tan JW, Wong PE, Yeo KK, Cook SA, Hausenloy DJ.

J Magn Reson Imaging. 2019 May 14. doi: 10.1002/jmri.26779. [Epub ahead of print] No abstract available.

PMID:
31087614
10.

Effect of Ischemic Preconditioning and Postconditioning on Exosome-Rich Fraction microRNA Levels, in Relation with Electrophysiological Parameters and Ventricular Arrhythmia in Experimental Closed-Chest Reperfused Myocardial Infarction.

Spannbauer A, Traxler D, Lukovic D, Zlabinger K, Winkler J, Gugerell A, Ferdinandy P, Hausenloy DJ, Pavo N, Emmert MY, Hoerstrup SP, Jakab A, Gyöngyösi M, Riesenhuber M.

Int J Mol Sci. 2019 Apr 30;20(9). pii: E2140. doi: 10.3390/ijms20092140.

11.

Translating Cardioprotection for Patient Benefit: The EU-CARDIOPROTECTION COST Action.

Hausenloy DJ, Heusch G.

J Am Coll Cardiol. 2019 Apr 23;73(15):2001-2003. doi: 10.1016/j.jacc.2019.03.020. No abstract available.

PMID:
31000004
12.

Sex Differences in 1-Year Rehospitalization for Heart Failure and Myocardial Infarction After Primary Percutaneous Coronary Intervention.

Zheng H, Foo LL, Tan HC, Richards AM, Chan SP, Lee CH, Low AFH, Hausenloy DJ, Tan JWC, Sahlen AO, Ho HH, Chai SC, Tong KL, Tan DSY, Yeo KK, Chua TSJ, Lam CSP, Chan MY.

Am J Cardiol. 2019 Jun 15;123(12):1935-1940. doi: 10.1016/j.amjcard.2019.03.021. Epub 2019 Mar 19.

PMID:
30979413
13.

Mineralocorticoid receptor antagonist pre-treatment and early post-treatment to minimize reperfusion injury after ST-elevation myocardial infarction: The MINIMIZE STEMI trial.

Bulluck H, Fröhlich GM, Nicholas JM, Mohdnazri S, Gamma R, Davies J, Sirker A, Mathur A, Blackman D, Garg P, Moon JC, Greenwood JP, Hausenloy DJ.

Am Heart J. 2019 May;211:60-67. doi: 10.1016/j.ahj.2019.02.005. Epub 2019 Feb 20.

14.

Shining the spotlight on cardioprotection: beyond the cardiomyocyte.

Davidson SM, Andreadou I, Garcia-Dorado D, Hausenloy DJ.

Cardiovasc Res. 2019 Jun 1;115(7):1115-1116. doi: 10.1093/cvr/cvz072. No abstract available.

PMID:
30865272
15.

Immune cells as targets for cardioprotection: new players and novel therapeutic opportunities.

Andreadou I, Cabrera-Fuentes HA, Devaux Y, Frangogiannis NG, Frantz S, Guzik T, Liehn EA, Gomes CPC, Schulz R, Hausenloy DJ.

Cardiovasc Res. 2019 Jun 1;115(7):1117-1130. doi: 10.1093/cvr/cvz050.

PMID:
30825305
16.

Cardiac innervation in acute myocardial ischaemia/reperfusion injury and cardioprotection.

Hausenloy DJ, Bøtker HE, Ferdinandy P, Heusch G, Ng GA, Redington A, Garcia-Dorado D.

Cardiovasc Res. 2019 Jun 1;115(7):1167-1177. doi: 10.1093/cvr/cvz053.

PMID:
30796814
17.

The Role of O-GlcNAcylation for Protection against Ischemia-Reperfusion Injury.

Jensen RV, Andreadou I, Hausenloy DJ, Bøtker HE.

Int J Mol Sci. 2019 Jan 18;20(2). pii: E404. doi: 10.3390/ijms20020404. Review.

18.

ESC Working Group on Cellular Biology of the Heart: position paper for Cardiovascular Research: tissue engineering strategies combined with cell therapies for cardiac repair in ischaemic heart disease and heart failure.

Madonna R, Van Laake LW, Botker HE, Davidson SM, De Caterina R, Engel FB, Eschenhagen T, Fernandez-Aviles F, Hausenloy DJ, Hulot JS, Lecour S, Leor J, Menasché P, Pesce M, Perrino C, Prunier F, Van Linthout S, Ytrehus K, Zimmermann WH, Ferdinandy P, Sluijter JPG.

Cardiovasc Res. 2019 Mar 1;115(3):488-500. doi: 10.1093/cvr/cvz010.

PMID:
30657875
19.

FURIN Inhibition Reduces Vascular Remodeling and Atherosclerotic Lesion Progression in Mice.

Yakala GK, Cabrera-Fuentes HA, Crespo-Avilan GE, Rattanasopa C, Burlacu A, George BL, Anand K, Mayan DC, Corlianò M, Hernández-Reséndiz S, Wu Z, Schwerk AMK, Tan ALJ, Trigueros-Motos L, Chèvre R, Chua T, Kleemann R, Liehn EA, Hausenloy DJ, Ghosh S, Singaraja RR.

Arterioscler Thromb Vasc Biol. 2019 Mar;39(3):387-401. doi: 10.1161/ATVBAHA.118.311903.

PMID:
30651003
20.

Sevoflurane, Propofol and Carvedilol Block Myocardial Protection by Limb Remote Ischemic Preconditioning.

Cho YJ, Nam K, Kim TK, Choi SW, Kim SJ, Hausenloy DJ, Jeon Y.

Int J Mol Sci. 2019 Jan 11;20(2). pii: E269. doi: 10.3390/ijms20020269.

Supplemental Content

Loading ...
Support Center